We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Allergy and Ashthma in Children Who Were Fed Supplemented Infant Formula

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01205659
Recruitment Status : Completed
First Posted : September 20, 2010
Last Update Posted : September 20, 2010
Sponsor:
Information provided by:

Study Description
Brief Summary:
Allergy and Asthma study of children (3 - 7 Years of age) who participated in randomized trials of supplemented infant formula during infancy conducted by The Retina Foundation of the Southwest .

Condition or disease
Allergy and Asthma

Study Design

Study Type : Observational
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Allergy and Asthma in Children Who Were Fed Supplemented Infant Formula (3-7 Years of Age)
Study Start Date : December 2008
Primary Completion Date : December 2009
Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Prevalence of asthma and allergy related diagnosis in medical records for ages 3 - 7 years

Secondary Outcome Measures :
  1. Prevalence of Serious Adverse Events in medical records
  2. Long-term growth

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   3 Years to 7 Years   (Child)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
Children who participated in randomizaed trials of supplemented infant formula conducted by The Retina Foundation of the Southwest during infancy
Criteria

Inclusion Criteria:

  • Children who participated in randomized trials of supplemented infant formula conducted by The Retina Foundation of the Southwest during infancy

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01205659


Locations
United States, Texas
The Retina Foundation of The Southwest
Dallas, Texas, United States, 75231
Sponsors and Collaborators
Mead Johnson Nutrition
More Information

Responsible Party: Eileen Birch, The Retina Foundation of the Southwest
ClinicalTrials.gov Identifier: NCT01205659     History of Changes
Other Study ID Numbers: 8611
First Posted: September 20, 2010    Key Record Dates
Last Update Posted: September 20, 2010
Last Verified: September 2010

Additional relevant MeSH terms:
Asthma
Hypersensitivity
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases